Editorial: Antiplatelet Agents in Stroke Prevention.
作者信息
Feher Gergely, Hargroves David, Illes Zsolt, Klivenyi Peter, Liu Liping, Szapary Laszlo
机构信息
Centre for Occupational Medicine, Medical School, University of Pécs, Pécs, Hungary.
East Kent Hospitals University NHS Foundation Trust, Ashford, United Kingdom.
出版信息
Front Neurol. 2021 Sep 28;12:762060. doi: 10.3389/fneur.2021.762060. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Antiplatelet Agents in Stroke Prevention.社论：预防中风的抗血小板药物
Front Neurol. 2021 Sep 28;12:762060. doi: 10.3389/fneur.2021.762060. eCollection 2021.
2
Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention.多因素导致抗血小板药物用于卒中预防的生物反应降低。
Medicina (Kaunas). 2021 Jan 10;57(1):59. doi: 10.3390/medicina57010059.
3
New modalities and aspects of antiplatelet therapy for stroke prevention.预防中风的抗血小板治疗的新方法和新进展。
Cerebrovasc Dis. 2006;21 Suppl 1:7-16. doi: 10.1159/000090357. Epub 2006 Feb 13.
4
Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials.抗血小板治疗对腔隙性卒中二级预防的疗效：随机试验的汇总分析。
Stroke. 2015 Apr;46(4):1014-23. doi: 10.1161/STROKEAHA.114.008422. Epub 2015 Feb 26.
5
When a Single Antiplatelet Agent for Stroke Prevention Is Not Enough: Current Evidence and Future Applications of Dual Antiplatelet Therapy.当单一抗血小板药物预防卒中不足时：双重抗血小板治疗的当前证据与未来应用
Curr Treat Options Cardiovasc Med. 2016 Apr;18(4):26. doi: 10.1007/s11936-016-0449-7.
6
Antiplatelet therapy in acute cerebral ischemia.
Stroke. 1999 Apr;30(4):887-93. doi: 10.1161/01.str.30.4.887.
7
Comparison of Antiplatelet Therapies for Prevention of Patent Foramen Ovale-Associated Stroke.预防卵圆孔未闭相关卒中的抗血小板治疗比较。
J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104632. doi: 10.1016/j.jstrokecerebrovasdis.2019.104632. Epub 2020 Feb 7.
8
Antiplatelet Agents in Secondary Stroke Prevention: Selection, Timing, and Dose.二级卒中预防中的抗血小板药物：选择、时机与剂量
Curr Treat Options Neurol. 2018 Jun 23;20(8):32. doi: 10.1007/s11940-018-0514-5.
9
Is the measurement of cerebral microembolic signals a good surrogate marker for evaluating the efficacy of antiplatelet agents in the prevention of stroke?
Eur Neurol. 2005;53(3):132-9. doi: 10.1159/000085569. Epub 2005 Apr 29.
10
Changes in antiplatelet use prior to incident ischaemic stroke over 7 years in a UK centre and the association with stroke subtype.在英国中心，7 年内发生缺血性中风前抗血小板药物使用的变化及其与中风亚型的关系。
Age Ageing. 2013 Sep;42(5):594-8. doi: 10.1093/ageing/aft075. Epub 2013 Jul 5.
本文引用的文献
1
A systematic review of the status and methodological considerations for estimating risk of first ever stroke in the general population.一项关于在普通人群中估算首次脑卒中风险的现状和方法学考虑的系统评价。
Neurol Sci. 2021 Jun;42(6):2235-2247. doi: 10.1007/s10072-021-05219-w. Epub 2021 Mar 30.
2
Risk Factors for Bleeding and Clinical Ineffectiveness Associated With Clopidogrel Therapy: A Comprehensive Meta-Analysis.与氯吡格雷治疗相关的出血风险因素和临床无效性：一项综合荟萃分析。
Clin Transl Sci. 2021 Mar;14(2):645-655. doi: 10.1111/cts.12926. Epub 2020 Dec 5.
3
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担：2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
4
Safety of Glycoprotein IIb-IIIa Inhibitors Used in Stroke-Related Treatment: A Systematic Review and Meta-Analysis.卒中相关性治疗中使用糖蛋白 IIb-IIIa 抑制剂的安全性：系统评价和荟萃分析。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620942594. doi: 10.1177/1076029620942594.
5
Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: A systematic review and meta-analysis.双重抗血小板预处理对接受 IV 溶栓治疗的缺血性脑卒中患者的安全性和疗效：系统评价和荟萃分析。
Neurology. 2020 Feb 18;94(7):e657-e666. doi: 10.1212/WNL.0000000000008961. Epub 2020 Jan 20.
6
Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial.普拉格雷和氯吡格雷治疗急性冠脉综合征患者的血小板反应性与临床结局：TROPICAL-ACS 试验的预先设定探索性分析。
Eur Heart J. 2019 Jun 21;40(24):1942-1951. doi: 10.1093/eurheartj/ehz202.
7
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.更新的血小板功能和基因检测指导经皮冠状动脉介入治疗中 P2Y 受体抑制剂治疗的专家共识声明。
JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537. doi: 10.1016/j.jcin.2019.03.034. Epub 2019 Jun 12.
8
L-arginine pathway metabolites can discriminate paroxysmal from permanent atrial fibrillation in acute ischemic stroke.L-精氨酸途径代谢物可区分急性缺血性卒中患者的阵发性房颤与永久性房颤。
Ideggyogy Sz. 2019 Mar 30;72(3-4):79-88. doi: 10.18071/isz.72.0079.
9
Updates on Prevention of Hemorrhagic and Lacunar Strokes.出血性和腔隙性卒中预防的最新进展
J Stroke. 2018 May;20(2):167-179. doi: 10.5853/jos.2018.00787. Epub 2018 May 31.
10
Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications.血小板聚集检测：分子机制、技术及临床意义
Int J Mol Sci. 2017 Aug 18;18(8):1803. doi: 10.3390/ijms18081803.
Zotero 插件